Marley Spoon making a disillusioned exit from the ASX
Nick Sundich, April 26, 2023
Marley Spoon‘s (ASX:MMM) tenure on the ASX looks like it is almost over. The company announced a fundraising deal that will result in it joining forces with an SPAC company and delisting from the ASX.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
Marley Spoon
Since Marley Spoon listed in late 2018 it has been a rollercoaster ride. Shares skyrocketed from 25c to $3.55 in the first 6 months of the pandemic as demand for food delivery services boomed.
But, just like its peers, Marley Spoon never made a cent of profit and was in an ultra-competitive industry. The company recorded its inaugural positive EBITDA result (€5m) in the December quarter of CY22, but lost €11.9m from operating activities.
Marley Spoon is making an exit
This morning, the company announced a fundraising deal that would see A$52m in fresh capital being injected as well as a Business Combination Agreement (BCA) with a Special Purpose Acquisition Company (SPAC) that is affiliated with one of Marley’s biggest shareholders (468 Capital).
The deal will see it end its listing in Australia and be solely listed in Germany. This would represent a 92% loss for shareholders who bought in at the company’s $1.42 per share IPO price in late 2018. But to be fair, it has company – Youfoodz listed in December 2020 at $1.57 per share and delisted just 7 months later having sold itself for 90c a share.
This will leave My Foodie Box (ASX:MBX) and My Food Bag (ASX:MFB) as the only two food delivery stocks, which are nursing post-listing returns of >90% and >75% respectively.
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
There’s no credit card needed – the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Analysts aren’t optimistic about iron ore prices in 2025, will they be right and what will it mean for iron ore stocks?
In which direction will iron ore prices in 2025 go? Chinese trade data would suggest upwards, and indeed prices jumped…
Paradigm Biopharmaceuticals’ flagship drug Zilosul will be in Phase 3 in 2025
Paradigm Biopharmaceuticals (ASX:PAR) has been listed for nearly a decade with the goal of bringing its flagship drug pentosan polysulfate…
Findi (ASX:FND): Its quadrupled in 12 months off the back of financial services in India
Until Findi (ASX:FND) came along, there were practically no ASX companies making money from India (or at least not many…